PMGC Holdings (ELAB) Other Operating Expenses (2022 - 2026)
PMGC Holdings (ELAB) posted Other Operating Expenses of -$64245.0 for Q1 2026, up 60.35% sequentially from -$162045.0 in Q4 2025.
PMGC Holdings (ELAB) Other Operating Expenses (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Other Operating Expenses for 5 years, with the latest figure at -$64245.0 in Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to -$64245.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 75.97% YoY) and the FY2025 annual result came in at -$32432.0, down 101.28% from the prior year.
- Other Operating Expenses advanced to -$64245.0 in Q1 2026 per ELAB's latest filing, from -$162045.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $322.3 million in Q3 2022 and troughed at -$2.0 million in Q3 2023.
- A 5-year average of $25.5 million and a median of $462422.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses soared 458.18% in 2023, then slumped 153.2% in 2024.
- Over 5 years, Other Operating Expenses stood at $1.5 million in 2022, then jumped by 458.18% to $8.6 million in 2023, then tumbled by 104.44% to -$383151.0 in 2024, then jumped by 57.71% to -$162045.0 in 2025, then surged by 60.35% to -$64245.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$64245.0, -$162045.0, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64,245.00 |
| Dec 31, 2025 | -162,045.00 |
| Sep 30, 2025 | 1.54 Mn |
| Dec 31, 2024 | -383,151.00 |
| Sep 30, 2024 | 664,670.00 |
| Jun 30, 2024 | 462,422.00 |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Sep 30, 2023 | -2.02 Mn |
| Jun 30, 2023 | 609,075.00 |
| Mar 31, 2023 | -492,938.00 |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 322.33 Mn |